• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 9-23 of 144 results

20 Refund Request: PETITIONERS REQUEST FOR REFUND OF IPR FEES

Document IPR2020-00440, No. 20 Refund Request - PETITIONERS REQUEST FOR REFUND OF IPR FEES (P.T.A.B. Mar. 17, 2022)

cite Cite Document

16 Reply: Authorized Reply to Patent Owners Preliminary Response

Document IPR2020-00440, No. 16 Reply - Authorized Reply to Patent Owners Preliminary Response (P.T.A.B. Jul. 20, 2020)

cite Cite Document

14 Reply: Patent Owners Authorized Surreply

Document IPR2020-00440, No. 14 Reply - Patent Owners Authorized Surreply (P.T.A.B. Jul. 17, 2020)

cite Cite Document

12 Reply: AUTHORIZED REPLY TO PATENT OWNERS PRELIMINARY RESPONSE

Document IPR2020-00440, No. 12 Reply - AUTHORIZED REPLY TO PATENT OWNERS PRELIMINARY RESPONSE (P.T.A.B. Jul. 10, 2020)

cite Cite Document

19 Notice: Petitioner Mylan Laboratories Ltd First Updated Mandatory Notice

Document IPR2020-00440, No. 19 Notice - Petitioner Mylan Laboratories Ltd First Updated Mandatory Notice (P.T.A.B. Dec. 2, 2020)

cite Cite Document

18 Notice: Petitioners Notice of Appeal

Document IPR2020-00440, No. 18 Notice - Petitioners Notice of Appeal (P.T.A.B. Oct. 20, 2020)

cite Cite Document

3 Petition: IPR Petition

Document IPR2020-00440, No. 3 Petition - IPR Petition (P.T.A.B. Feb. 7, 2020)

cite Cite Document

13 Exhibit List: Updated Exhibit List

Document IPR2020-00440, No. 13 Exhibit List - Updated Exhibit List (P.T.A.B. Jul. 10, 2020)

cite Cite Document

9 Notice: Petitioners Updated Exhibit List

Document IPR2020-00440, No. 9 Notice - Petitioners Updated Exhibit List (P.T.A.B. Jun. 30, 2020)

cite Cite Document

8 Preliminary Response: Patent Owners Preliminary Response

Document IPR2020-00440, No. 8 Preliminary Response - Patent Owners Preliminary Response (P.T.A.B. Jun. 19, 2020)

cite Cite Document

6 Mandatory Notice: Janssen Pharmaceutica NVs Mandatory Notices

Document IPR2020-00440, No. 6 Mandatory Notice - Janssen Pharmaceutica NVs Mandatory Notices (P.T.A.B. Feb. 28, 2020)

cite Cite Document

5 Power of Attorney: Janssen Pharmaceutica NVs Power of Attorney

Document IPR2020-00440, No. 5 Power of Attorney - Janssen Pharmaceutica NVs Power of Attorney (P.T.A.B. Feb. 28, 2020)

cite Cite Document

2 Exhibit List: Exhibit List

Document IPR2020-00440, No. 2 Exhibit List - Exhibit List (P.T.A.B. Feb. 7, 2020)

cite Cite Document

1 Power of Attorney: Power of Attorney

Document IPR2020-00440, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Feb. 7, 2020)

cite Cite Document

1049 Exhibit: Exhibit 1049 Clinical Trials Comparison of Paliperidone Palmitate and...

Document IPR2020-00440, No. 1049-70 Exhibit - Exhibit 1049 Clinical Trials Comparison of Paliperidone Palmitate andRISPERDAL CONSTA in Patients With Schizophrenia (P.T.A.B. Jul. 10, 2020)

cite Cite Document
<< 1 2 3 4 5 ... 9 10 11 >>